These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32930492)

  • 1. Amplatzer left atrial appendage closure: Single versus combined procedures.
    Kleinecke C; Buffle E; Link J; Häner J; Sedaghat A; Galea R; Streit SR; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E973-E981. PubMed ID: 32930492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of Watchman vs. Amplatzer occluders for left atrial appendage closure (WATCH at LAAC).
    Kleinecke C; Yu J; Neef P; Buffle E; de Marchi S; Fuerholz M; Nietlispach F; Valgimigli M; Streit SR; Fankhauser M; Duenninger E; Windecker S; Meier B; Gloekler S
    Europace; 2020 Jun; 22(6):916-923. PubMed ID: 32003774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcomes of Amplatzer cardiac plug versus Amulet occluders for left atrial appendage closure.
    Kleinecke C; Cheikh-Ibrahim M; Schnupp S; Fankhauser M; Nietlispach F; Park JW; Brachmann J; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E324-E331. PubMed ID: 31631493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure.
    Schnupp S; Liu XX; Buffle E; Gloekler S; Mohrez Y; Cheikh-Ibrahim M; Allakkis W; Brachmann J; Park JW; Kleinecke C
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):934-942. PubMed ID: 32072692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of individual stroke risk on outcome after Amplatzer left atrial appendage closure in patients with atrial fibrillation.
    Häner JD; Fürholz M; Kleinecke C; Galea R; Streit SR; Fankhauser M; Cherni T; Valgimigli M; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1002-E1010. PubMed ID: 33022121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
    Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study.
    Gloekler S; Fürholz M; de Marchi S; Kleinecke C; Streit SR; Buffle E; Fankhauser M; Häner JD; Nietlispach F; Galea R; Windecker S; Meier B
    EuroIntervention; 2020 Oct; 16(9):e767-774. PubMed ID: 32583806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transseptal puncture versus patent foramen ovale or atrial septal defect access for left atrial appendage closure.
    Kleinecke C; Fuerholz M; Buffle E; de Marchi S; Schnupp S; Brachmann J; Nietlispach F; Fankhauser M; Streit SR; Windecker S; Meier B; Gloekler S
    EuroIntervention; 2020 Jun; 16(2):e173-e180. PubMed ID: 31449043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.
    Gloekler S; Shakir S; Doblies J; Khattab AA; Praz F; Guerios Ê; Koermendy D; Stortecky S; Pilgrim T; Buellesfeld L; Wenaweser P; Windecker S; Moschovitis A; Jaguszewski M; Landmesser U; Nietlispach F; Meier B
    Clin Res Cardiol; 2015 Aug; 104(8):656-65. PubMed ID: 25736061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation.
    Kuwata S; Vierecke J; Gloekler S; Maisano F; Meier B; Nietlispach F
    Cardiol J; 2018; 25(2):179-187. PubMed ID: 28840592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years.
    Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L
    Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure.
    Guérios ÊE; Chamié F; Montenegro M; Saad EB; Brito FS; Caramori PA; Simões LC; Oliveira FRA; Giuliano LC; Tavares CMDF
    Arq Bras Cardiol; 2017 Nov; 109(5):440-447. PubMed ID: 29069203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplatzer left atrial appendage occlusion: single center 10-year experience.
    Nietlispach F; Gloekler S; Krause R; Shakir S; Schmid M; Khattab AA; Wenaweser P; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):283-9. PubMed ID: 23412815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplatzer left atrial appendage occlusion through a patent foramen ovale.
    Koermendy D; Nietlispach F; Shakir S; Gloekler S; Wenaweser P; Windecker S; Khattab AA; Meier B
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1190-6. PubMed ID: 24399612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing safety and efficacy: MemoLefort versus watchman for left atrial appendage closure.
    Li L; Qian S; Fu JY; Wang ZN; Jiang T; Lin YN; Yao T; Liu JC; Pan YQ; Li YC
    Int J Cardiol; 2024 Mar; 398():131641. PubMed ID: 38065328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.